Literature DB >> 25548226

Antibody-mediated trapping of helminth larvae requires CD11b and Fcγ receptor I.

Julia Esser-von Bieren1, Beatrice Volpe1, Manuel Kulagin1, Duncan B Sutherland1, Romain Guiet2, Arne Seitz2, Benjamin J Marsland3, J Sjef Verbeek4, Nicola L Harris5.   

Abstract

Infections with intestinal helminths severely impact on human and veterinary health, particularly through the damage that these large parasites inflict when migrating through host tissues. Host immunity often targets the motility of tissue-migrating helminth larvae, which ideally should be mimicked by anti-helminth vaccines. However, the mechanisms of larval trapping are still poorly defined. We have recently reported an important role for Abs in the rapid trapping of tissue-migrating larvae of the murine parasite Heligmosomoides polygyrus bakeri. Trapping was mediated by macrophages (MΦ) and involved complement, activating FcRs, and Arginase-1 (Arg1) activity. However, the receptors and Ab isotypes responsible for MΦ adherence and Arg1 induction remained unclear. Using an in vitro coculture assay of H. polygyrus bakeri larvae and bone marrow-derived MΦ, we now identify CD11b as the major complement receptor mediating MΦ adherence to the larval surface. However, larval immobilization was largely independent of CD11b and instead required the activating IgG receptor FcγRI (CD64) both in vitro and during challenge H. polygyrus bakeri infection in vivo. FcγRI signaling also contributed to the upregulation of MΦ Arg1 expression in vitro and in vivo. Finally, IgG2a/c was the major IgG subtype from early immune serum bound by FcγRI on the MΦ surface, and purified IgG2c could trigger larval immobilization and Arg1 expression in MΦ in vitro. Our findings reveal a novel role for IgG2a/c-FcγRI-driven MΦ activation in the efficient trapping of tissue-migrating helminth larvae and thus provide important mechanistic insights vital for anti-helminth vaccine development.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25548226      PMCID: PMC4298127          DOI: 10.4049/jimmunol.1401645

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  Interaction of two phagocytic host defense systems: Fcγ receptors and complement receptor 3.

Authors:  Zhen-Yu Huang; Sharon Hunter; Paul Chien; Moo-Kyung Kim; Tae-Hee Han-Kim; Zena K Indik; Alan D Schreiber
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

2.  C-type lectins on macrophages participate in the immunomodulatory response to Fasciola hepatica products.

Authors:  Lorena Guasconi; Marianela C Serradell; Ana P Garro; Luciana Iacobelli; Diana T Masih
Journal:  Immunology       Date:  2011-05-20       Impact factor: 7.397

Review 3.  Diversity and dialogue in immunity to helminths.

Authors:  Judith E Allen; Rick M Maizels
Journal:  Nat Rev Immunol       Date:  2011-06       Impact factor: 53.106

Review 4.  A role for interleukin-33 in T(H)2-polarized intestinal inflammation?

Authors:  J B Seidelin; G Rogler; O H Nielsen
Journal:  Mucosal Immunol       Date:  2011-05-25       Impact factor: 7.313

5.  Increased frequency of surface IgA-positive plasma cells in the intestinal lamina propria and decreased IgA excretion in hyper IgA (HIGA) mice, a murine model of IgA nephropathy with hyperserum IgA.

Authors:  T Kamata; F Nogaki; S Fagarasan; T Sakiyama; I Kobayashi; S Miyawaki; K Ikuta; E Muso; H Yoshida; S Sasayama; T Honjo
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

6.  Heligmosomoides polygyrus elicits a dominant nonprotective antibody response directed against restricted glycan and peptide epitopes.

Authors:  James P Hewitson; Kara J Filbey; John R Grainger; Adam A Dowle; Mark Pearson; Janice Murray; Yvonne Harcus; Rick M Maizels
Journal:  J Immunol       Date:  2011-09-30       Impact factor: 5.422

7.  Advances in helminth immunology: optimism for future vaccine design?

Authors:  Nicola L Harris
Journal:  Trends Parasitol       Date:  2011-04-30

8.  Absence of interleukin-4 enhances germinal center reaction in secondary immune response.

Authors:  A Andoh; A Masuda; M Yamakawa; Y Kumazawa; T Kasajima
Journal:  Immunol Lett       Date:  2000-07-03       Impact factor: 3.685

9.  Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation.

Authors:  Stephen J Jenkins; Dominik Ruckerl; Peter C Cook; Lucy H Jones; Fred D Finkelman; Nico van Rooijen; Andrew S MacDonald; Judith E Allen
Journal:  Science       Date:  2011-05-12       Impact factor: 47.728

10.  Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens.

Authors:  Judith E Allen; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2011-05-12       Impact factor: 6.823

View more
  10 in total

Review 1.  Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space.

Authors:  Anupama Ariyaratne; Constance A M Finney
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

2.  Microbial regulation of intestinal motility provides resistance against helminth infection.

Authors:  Mati Moyat; Luc Lebon; Olaf Perdijk; Lakshanie C Wickramasinghe; Mario M Zaiss; Ilaria Mosconi; Beatrice Volpe; Nadine Guenat; Kathleen Shah; Gillian Coakley; Tiffany Bouchery; Nicola L Harris
Journal:  Mucosal Immunol       Date:  2022-03-14       Impact factor: 8.701

Review 3.  Context-dependent roles of B cells during intestinal helminth infection.

Authors:  Aidil Zaini; Kim L Good-Jacobson; Colby Zaph
Journal:  PLoS Negl Trop Dis       Date:  2021-05-13

4.  Immune antibodies and helminth products drive CXCR2-dependent macrophage-myofibroblast crosstalk to promote intestinal repair.

Authors:  Julia Esser-von Bieren; Beatrice Volpe; Duncan B Sutherland; Jérôme Bürgi; J Sjef Verbeek; Benjamin J Marsland; Joseph F Urban; Nicola L Harris
Journal:  PLoS Pathog       Date:  2015-03-25       Impact factor: 6.823

Review 5.  Macrophage Activation and Functions during Helminth Infection: Recent Advances from the Laboratory Mouse.

Authors:  Marion Rolot; Benjamin G Dewals
Journal:  J Immunol Res       Date:  2018-07-02       Impact factor: 4.818

6.  β-Glucan receptors on IL-4 activated macrophages are required for hookworm larvae recognition and trapping.

Authors:  Tiffany Bouchery; Beatrice Volpe; Rory Doolan; Gillian Coakley; Mati Moyat; Julia Esser-von Bieren; Lakshanie C Wickramasinghe; Margaret L Hibbs; Javier Sotillo; Mali Camberis; Graham Le Gros; Nemat Khan; David Williams; Nicola L Harris
Journal:  Immunol Cell Biol       Date:  2022-03-10       Impact factor: 5.853

7.  A newly identified secreted larval antigen elicits basophil-dependent protective immunity against N. brasiliensis infection.

Authors:  Natalie Thuma; Daniela Döhler; Dirk Mielenz; Heinrich Sticht; Daniel Radtke; Lena Reimann; Bettina Warscheid; David Voehringer
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

8.  Transgenic expression of a T cell epitope in Strongyloides ratti reveals that helminth-specific CD4+ T cells constitute both Th2 and Treg populations.

Authors:  Bonnie Douglas; Yun Wei; Xinshe Li; Annabel Ferguson; Li-Yin Hung; Christopher Pastore; Jonathan R Kurtz; James B McLachlan; Thomas J Nolan; James Lok; De'Broski R Herbert
Journal:  PLoS Pathog       Date:  2021-07-08       Impact factor: 6.823

9.  Epithelial-Cell-Derived Phospholipase A2 Group 1B Is an Endogenous Anthelmintic.

Authors:  Lewis J Entwistle; Victoria S Pelly; Stephanie M Coomes; Yashaswini Kannan; Jimena Perez-Lloret; Stephanie Czieso; Mariana Silva Dos Santos; James I MacRae; Lucy Collinson; Abdul Sesay; Nikolay Nikolov; Amina Metidji; Helena Helmby; David Y Hui; Mark S Wilson
Journal:  Cell Host Microbe       Date:  2017-10-11       Impact factor: 21.023

Review 10.  Host-Parasite Interactions Promote Disease Tolerance to Intestinal Helminth Infection.

Authors:  Irah L King; Yue Li
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.